Chief Medical Officer · Vigil Neuroscience, Inc. (VIGL)

Petra Kaufmann

FY2024 is the first fiscal year CompBrief holds for Petra Kaufmann as a named executive officer of Vigil Neuroscience; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,267,847

Salary $380,000Stock awards $0

2nd of 3 named executive officers at Vigil Neuroscience by FY2024 total.

3 named officers on file for Vigil Neuroscience, FY2024

Petra Kaufmann’s pay file — $29

  • 1 fiscal year of pay, line by line
  • VIGL’s disclosed peer group of 1 company

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Vigil Neuroscience’s whole pay program stands against its peers

  • Vigil Neuroscience’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on VIGL→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 31, 2025 (DEF 14A).

Free

Get Petra Kaufmann’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Petra Kaufmann compensation by year

Vigil Neuroscience Summary Compensation Table · the one fiscal year held
In US dollars, as Vigil Neuroscience reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$380,000
Bonus$0
Stock awards$0
Option awards$704,550
Non-equity incentive$139,860
Pension and deferred compensation$0
All other$43,437
Total$1,267,847

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Vigil Neuroscience, Inc. DEF 14A filed March 31, 2025, accession 0001193125-25-067733, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Vigil Neuroscience, Inc. filed document, accession 0001193125-25-067733. Every figure is read from that document and cited to the page and table it appears in. Filed March 31, 2025.

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
Option330,000—$3.14

Per the Outstanding Equity Awards at Fiscal Year-End table in Vigil Neuroscience, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Vigil Neuroscience’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Ivana Magovčević-LiebischPresident and Chief Executive Officer$2,633,571
Petra Kaufmann · this pageChief Medical Officer$1,267,847
Jennifer ZiolkowskiChief Financial Officer$1,246,795

The full Vigil Neuroscience compensation record

free company brief

This page is one person within Vigil Neuroscience's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Vigil Neuroscience's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Petra Kaufmann's compensation dossier · One-time report. No refunds.